Prosecution Insights
Last updated: October 02, 2026

Examiner: DAKKAK, JIHAD

Tech Center 3700 • Art Units: 1627 3772 3781

This examiner grants 49% of resolved cases

Analysis

Jihad Dakkak serves in Tech Center 3700 and Art Unit 1627. He has managed 71 resolved cases. His allowance rate is 49.3 percent, which indicates the probability of success for applicants. The median days to allowance is 1119, which is a timeframe for the examination process. These figures are based on the 71 resolved cases currently associated with his profile.

The interview lift for Dakkak is 46.0 percent. This is a high lift, suggesting that interviews are effective at moving cases toward allowance. In Art Unit 1627, the 49.3 percent allowance rate is a key performance metric. Practitioners should prioritize interviews when working with Dakkak, given the 46.0 percent interview lift in Tech Center 3700.

The 1119 days to allowance provides a benchmark for the expected timeline. With a 49.3 percent allowance rate, the examiner's profile suggests that engagement through interviews can be beneficial. The 46.0 percent interview lift is a relevant metric for applicants seeking to improve their results in Art Unit 1627 and Tech Center 3700.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

49.3%
Allow Rate
-20.7% vs TC avg
110
Total Applications
+46.0%
Interview Lift
1119
Avg Prosecution Days
Based on 71 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
22.2%
§102 Novelty
58.8%
§103 Obviousness
15.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19032527 FEMININE HYGIENE PRODUCT INCLUDING A CRIMPED REGION AND ASSOCIATED METHOD Non-Final OA The Procter & Gamble Company
18913165 BELT ASSEMBLIES FOR ABSORBENT ARTICLES Non-Final OA The Procter & Gamble Company
18427336 DRESSING INTERFACE WITH MICRO-NEEDLES FOR NEGATIVE-PRESSURE TREATMENT Non-Final OA Solventum Intellectual Properties Company
18424279 MICRO-POROUS CONDUIT Non-Final OA Solventum Intellectual Properties Company
17770488 BIDIRECTIONAL PERFUSION CANNULA Non-Final OA MEDTRONIC, INC.
17651622 FLUID REMOVAL DEVICE Non-Final OA Medline Industries, LP
18997775 ADJUSTABLE SHUNTS WITH SHAPE MEMORY ACTUATORS AND ASSOCIATED SYSTEMS AND METHODS Non-Final OA Shifamed Holdings, LLC
17778976 EASY EMPTY URINE COLLECTION BAGS Non-Final OA Hollister Incorporated
17792269 CONNECTING ARRANGEMENT, CONNECTING SYSTEM, CONTAINER AND CONTAINER SYSTEM Final Rejection BOEHRINGER INGELHEIM VETMEDICA GMBH
18715612 WRAPPER FOR ABSORBENT ARTICLE Non-Final OA ONTEX GROUP NV
17655464 FLUID COLLECTION SYSTEM INCLUDING A COMPRESSIBLE SUCTION DEVICE AND RELATED METHODS Non-Final OA PureWick Corporation
18016371 A male urinary incontinence device Final Rejection Coloplast A/S
17766258 A MEDICAL DEVICE SYSTEM Non-Final OA Coloplast A/S
16970965 METHODS FOR MEDICAL APPLIANCE CHANGE AND RELATED ACCESSORY DEVICES OF A MEDICAL SYSTEM Final Rejection Coloplast A/S
18691395 NEGATIVE PRESSURE WOUND THERAPY SYSTEM Final Rejection KCI Manufacturing Unlimited Company
18688718 NEGATIVE PRESSURE DRESSING WITH DIFFERENTIAL COLLAPSING FORCE FOR WOUND CLOSURE Final Rejection KCI Manufacturing Unlimited Company
17747343 SUCTION HEAD FOR GENTLY SUCTIONING THIXOTROPIC LIQUIDS Final Rejection Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin
17560058 Inline Pressure and Temperature Sensor for Cerebral Shunts Final Rejection Cognos Therapeutics Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month